New Triple-Action cancer drug enters human testing
Disease control
Recruiting now
This is an early-stage study testing a new experimental drug called CS2009 in people with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find a safe dose and see if the drug shows any early signs of fighting the cancer. The drug i…
Phase: PHASE1, PHASE2 • Sponsor: CStone Pharmaceuticals • Aim: Disease control
Last updated Mar 24, 2026 12:03 UTC